Hygeia Healthcare Holdings 관리

관리 기준 확인 4/4

Hygeia Healthcare Holdings CEO는 Yiwen Zhu, Aug2021 에 임명되었습니다 의 임기는 3.25 년입니다. 총 연간 보상은 CN¥ 2.49M, 24.1% 로 구성됩니다. 24.1% 급여 및 75.9% 보너스(회사 주식 및 옵션 포함). 는 HK$ 4.60B 가치에 해당하는 회사 주식의 44.98% 직접 소유합니다. 4.60B. 경영진과 이사회의 평균 재임 기간은 각각 3.8 년과 5 년입니다.

주요 정보

Yiwen Zhu

최고 경영자

CN¥2.5m

총 보상

CEO 급여 비율	24.1%
CEO 임기	3.3yrs
CEO 소유권	45.0%
경영진 평균 재임 기간	3.8yrs
이사회 평균 재임 기간	5yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Yiwen Zhu 의 보수는 Hygeia Healthcare Holdings 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Jun 30 2024	n/a	n/a	CN¥733m
Mar 31 2024	n/a	n/a	CN¥708m
Dec 31 2023	CN¥2m	CN¥600k	CN¥683m
Sep 30 2023	n/a	n/a	CN¥635m
Jun 30 2023	n/a	n/a	CN¥587m
Mar 31 2023	n/a	n/a	CN¥532m
Dec 31 2022	CN¥4m	CN¥492k	CN¥477m
Sep 30 2022	n/a	n/a	CN¥472m
Jun 30 2022	n/a	n/a	CN¥468m
Mar 31 2022	n/a	n/a	CN¥455m
Dec 31 2021	CN¥709k	CN¥239k	CN¥441m
Sep 30 2021	n/a	n/a	CN¥403m
Jun 30 2021	n/a	n/a	CN¥365m
Mar 31 2021	n/a	n/a	CN¥268m
Dec 31 2020	CN¥45k	CN¥37k	CN¥170m
Sep 30 2020	n/a	n/a	CN¥100m
Jun 30 2020	n/a	n/a	CN¥29m
Mar 31 2020	n/a	n/a	CN¥35m
Dec 31 2019	CN¥779k	CN¥684k	CN¥40m

보상 대 시장: Yiwen 의 총 보상 ($USD 344.08K )은 Hong Kong 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 487.65K ).

보상과 수익: Yiwen 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Yiwen Zhu (60 yo)

3.3yrs

테뉴어

CN¥2,493,000

보상

Mr. Yiwen Zhu serves as Executive Director & Co-Chief Executive Officer of at Hygeia Healthcare Holdings Co., Limited since August 23, 2021. He serves as Chairman of the Board at Hygeia Healthcare Holdings...

리더십 팀

이름	위치	테뉴어	보상	소유권
Yiwen Zhu	Chairman & Co-CEO	3.3yrs	CN¥2.49m	44.98% HK$ 4.6b
Huanhuan Cheng	Co-CEO & Executive Director	3.3yrs	CN¥1.54m	데이터 없음
Wenshan Zhang	Director of Research & Development	4.8yrs	CN¥1.51m	0.0052% HK$ 528.4k
Hui Jiang	Director of Radiotherapy Division & Executive Director	3.9yrs	CN¥1.33m	데이터 없음
Ai Ren	Joint Company Secretary	no data	CN¥2.32m	0.46% HK$ 46.8m
Xue Yu	Financial Director	no data	데이터 없음	데이터 없음
Kwok Yin Lau	Joint Company Secretary	3.8yrs	데이터 없음	데이터 없음

3.8yrs

평균 재임 기간

42yo

평균 연령

경험이 풍부한 관리: 6078 의 관리팀은 경험 ( 3.8 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름	위치	테뉴어	보상	소유권
Yiwen Zhu	Chairman & Co-CEO	3.7yrs	CN¥2.49m	44.98% HK$ 4.6b
Huanhuan Cheng	Co-CEO & Executive Director	5.4yrs	CN¥1.54m	데이터 없음
Wenshan Zhang	Director of Research & Development	4.8yrs	CN¥1.51m	0.0052% HK$ 528.4k
Hui Jiang	Director of Radiotherapy Division & Executive Director	3.9yrs	CN¥1.33m	데이터 없음
Ai Ren	Joint Company Secretary	6.2yrs	CN¥2.32m	0.46% HK$ 46.8m
Changqing Ye	Independent Non-Executive Director	5.2yrs	CN¥240.00k	데이터 없음
Chun Zhao	Independent Non-Executive Director	2.5yrs	CN¥240.00k	데이터 없음
Yanqun Liu	Independent Non-Executive Director	5.2yrs	CN¥240.00k	데이터 없음

5.0yrs

평균 재임 기간

51yo

평균 연령

경험이 풍부한 이사회: 6078 의 이사회는 경험(평균 재직 기간 5 년)으로 간주됩니다.

Hygeia Healthcare Holdings 관리

관리 기준 확인 4/4

주요 정보

최근 관리 업데이트

Chairman & Co-CEO recently bought HK$13m worth of stock

Hygeia Healthcare Holdings Co., Limited, Annual General Meeting, Jun 28, 2024

Chairman & Co-CEO recently bought HK$4.1m worth of stock

Chairman & Co-CEO recently bought HK$20m worth of stock

Chairman & Co-CEO recently bought HK$9.0m worth of stock

Hygeia Healthcare Holdings Co., Limited Announces Chief Financial Officer Changes

Recent updates

Investor sentiment improves as stock rises 34%

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 21%

First half 2024 earnings released: EPS: CN¥0.61 (vs CN¥0.53 in 1H 2023)

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2024 Results on Aug 29, 2024

Full year 2023 earnings released: EPS: CN¥1.08 (vs CN¥0.77 in FY 2022)

Chairman & Co-CEO recently bought HK$13m worth of stock

Investor sentiment improves as stock rises 21%

Hygeia Healthcare Holdings Co., Limited, Annual General Meeting, Jun 28, 2024

Full year 2023 earnings released: EPS: CN¥1.08 (vs CN¥0.77 in FY 2022)

Hygeia Healthcare Holdings Co., Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 16%

Chairman & Co-CEO recently bought HK$4.1m worth of stock

Chairman & Co-CEO recently bought HK$20m worth of stock

Investor sentiment deteriorates as stock falls 24%

Chairman & Co-CEO recently bought HK$9.0m worth of stock

First half 2023 earnings released: EPS: CN¥0.53 (vs CN¥0.36 in 1H 2022)

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2023 Results on Aug 29, 2023

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) entered into the acquisition agreement to acquire Datang International (Hong Kong) Limited for CNY 1.2 billion.

Now 22% undervalued after recent price drop

Upcoming dividend of CN¥0.15 per share at 0.4% yield

Full year 2022 earnings released: EPS: CN¥0.77 (vs CN¥0.71 in FY 2021)

Hygeia Healthcare Holdings Co., Limited has completed a Follow-on Equity Offering in the amount of HKD 791.8 million.

Hygeia Healthcare Holdings Co., Limited Announces Chief Financial Officer Changes

Now 22% undervalued after recent price drop

Less than half of directors are independent

Now 22% undervalued after recent price drop

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) acquired 30% of KAIYUAN JIEHUA HOSPITAL CO., LTD for CNY 15.3 million.

First half 2022 earnings released: EPS: CN¥0.36 (vs CN¥0.32 in 1H 2021)

Hygeia Healthcare Holdings Co., Limited Omits Dividend for the Six Months Ended June 30, 2022

Hygeia Healthcare Holdings Co., Limited to Report First Half, 2022 Results on Aug 31, 2022

Investor sentiment improved over the past week

Hygeia Healthcare Holdings Co., Limited Announces Management Changes

Full year 2021 earnings released: EPS: CN¥0.71 (vs CN¥0.38 in FY 2020)

Less than half of directors are independent

Full year 2021 earnings released: EPS: CN¥0.71 (vs CN¥0.38 in FY 2020)

Hygeia Healthcare Holdings Co., Limited Resolves Not to Declare Final Dividend for the Year Ended December 31, 2021

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Chairman & Co-CEO recently bought HK$15m worth of stock

Joint Company Secretary recently bought HK$11m worth of stock

Investor sentiment deteriorated over the past week

Chairman & Co-CEO recently bought HK$4.4m worth of stock

First half 2021 earnings released: EPS CN¥0.32 (vs CN¥0.008 in 1H 2020)

First half 2021 earnings released: EPS CN¥0.32 (vs CN¥0.008 in 1H 2020)

Board Member recently sold HK$6.2m worth of stock

Director of Research & Development recently sold HK$2.7m worth of stock

Full year 2020 earnings released: EPS CN¥0.38 (vs CN¥0.14 in FY 2019)

Hygeia Healthcare Holdings Co., Limited (SEHK:6078) entered into a share purchase agreement to acquire 98% stake in Suzhou Yongding Hospital from Ascendent Capital Partners I, L.P. managed by Ascendent Capital Partners (Asia) Limited for CNY 1.7 billion.

Full year 2020 earnings released: EPS CN¥0.38 (vs CN¥0.14 in FY 2019)

Hygeia Healthcare Holdings Co., Limited to Report Fiscal Year 2020 Results on Mar 29, 2021

New 90-day low: HK$45.50

Hygeia Healthcare Holdings Co., Limited Announces Change of Joint Company Secretary

New 90-day high: HK$61.15

Hygeia Healthcare Holdings Co., Limited Announces Management Changes

Insider recently bought HK$8.2m worth of stock

First half earnings released

CEO 보상 분석

CEO

테뉴어

보상

리더십 팀

평균 재임 기간